Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Clinical trial NCT05379647 · UNKNOWN

Trial details

NCT number: NCT05379647
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma B-cell Acute Lymphoblastic Leukemia

Start date: 2021-11-04
Primary completion: 2024-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.